Submitted:
19 August 2024
Posted:
20 August 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Febré, N.; Silva, V.; Medeiros, E.A.S.; Wey, S.B.; Colombo, A.L.; Fischman, O. Microbiological characteristics of yeast isolated from urinary tracts of intensive care unit patients undergoing urinary catheterization. J Clin Microbiol 1999, 37, 1584–1586. [Google Scholar] [CrossRef] [PubMed]
- Silva, V.; Díaz, M.C.; Febré, N.; the Chilean Invasive Fungal Group. Chilean Invasive Fungal Group. Invasive fungal infections in Chile: A multicenter study of fungal prevalence and susceptibility during a 1-year period. Med Mycol 2004, 42, 333–339. [Google Scholar] [CrossRef] [PubMed]
- WHO fungal priority pathogens list to guide research, development and public health actions. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
- Sanchez, V.; Vazquez, J.A.; Barth-Jones, D.; Dembry, L.; Sobel, J.D.; Zervos, M.J. Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. Am J Med 1993, 94, 557–582. [Google Scholar] [CrossRef] [PubMed]
- Hedderwick, S.A.; Lyons, M.J.; Liu, M.; Vazquez, J.A.; Kauffman, C.A. Epidemiology of yeast colonization in the intensive care unit. Eur J Clin Microbiol Infect Dis 2000, 19, 663–670. [Google Scholar] [CrossRef]
- Nucci, M.; Queiroz-Telles, F.; Alvarado-Matute, T.; Tiraboschi, I.N.; Cortes, J.; Zurita, J.; et al. Epidemiology of candidemia in Latin America: A Laboratory- Based Survey. PloS ONE 2013, 8, e59373. [Google Scholar] [CrossRef]
- Silva, V.; Zaror, L. Diagnóstico Micológico en el Laboratorio Clínico, 1st ed.; Universidad Mayor: Santiago, Chile, 2015; p. 233. [Google Scholar]
- Pristov, K.E.; Ghannoum, M.A. Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect. 2019, 25, 792–798. [Google Scholar] [CrossRef] [PubMed]
- Bilal, H.; Shafiq, M.; Hou, B.; Islam, R.; Khan, M.N.; Khan, R.U.; Zeng, Y. Distribution and antifungal susceptibility pattern of Candida species from mainland China: A systematic analysis. Virulence 2022, 13, 1573–1589. [Google Scholar] [CrossRef]
- Fan, F.; Liu, Y.; Liu, Y.; Lv, R.; Sun, W.; Ding, W.; Cai, Y.; Li, W.; Liu, X.; Qu, W. Candida albicans biofilm: antifungal resistance, immune evasion, and emerging therapeutic strategies. Int J Antimicrob agents 2022, 60, 1–8. [Google Scholar] [CrossRef] [PubMed]
- Chowdhary, A.; Jain, K.; Chauhan, M. Candida auris genetics and emergence. Annu Rev Microbiol 2023, 77, 583–602. [Google Scholar] [CrossRef] [PubMed]
- Silva, V.; Zepeda, G.; Rybak, M.E.; Febre, N. Yeast carriage on the hands of Medicine students. Rev Iberoam Micol 2003, 20, 41–45. [Google Scholar] [PubMed]
- Clayton, Y.M.; Noble, W.C. Observations on the epidemiology of Candida albicans. J Clinic Pathol 1966, 19, 76–78. [Google Scholar] [CrossRef]
- Marples, M.J.; Somerville, D.A. The oral and cutaneous distribution of Candida albicans and other yeasts in Rarotonga, Cook Islands. Trans R Soc Trop Med Hyg 1968, 62, 256–262. [Google Scholar] [CrossRef] [PubMed]
- Horn, W.A.; Larson, E.L.; McGinley, K.J.; Leyden, J.J. Microbial flora on the hands of health care personnel: Differences in composition and antibacterial resistance. Infect Control Hosp Epidemiol 1988, 9, 189–193. [Google Scholar] [CrossRef] [PubMed]
- Strausbaugh, L.J.; Sewell, D.L.; Tjoelker, R. Comparison of three methods for recovery of yeasts from hands of health-care workers. J Clin Microbiol 1996, 34, 471–473. [Google Scholar] [CrossRef]
- Kumar, S.; Batra, R. A study of yeast carriage on hands of hospital personnel. Indian J Pathol Microbiol 2000, 43, 65–67. [Google Scholar] [PubMed]
- Yildirim, M.; Sahin, I.; Kucukbayrak, A.; Ozdemir, D.; Tevfik-Yavuz, M.; Oksuz, S.; Cakir, S. Hand carriage of Candida species and risk factors in hospital personnel. Mycoses 2007, 50, 189–92. [Google Scholar] [CrossRef]
- Muango, A.; Brevis, P.; Mora, C. Carriage of yeasts in the hands of the students of medicine and nursing careers at the University of Talca, Chile. Bol Micol 2017, 32, 8–14. [Google Scholar]
- Huang, Y.C.; Lin, T.Y.; Leu, H.S.; Wu, J.L.; Wu, J.H. Yeast carriage on hands of hospital personnel working in intensive care units. J Hosp Infect 1998, 39, 47–51. [Google Scholar] [CrossRef]
- Yildirim, M.; Sahim, I.; Oksuz, S.; Sencan, I.; Kucukbayrak, A.; Cakir, S.; Ozaydin, C. Hand carriage of Candida occurs at lesser rates in hospital personnel who use antimicrobial hand disinfectant. Scand J Infect Dis 2014, 49, 633–636. [Google Scholar] [CrossRef]
- Tavanti, A.; Davidson, A.D.; Gow, N.A.; Maiden, M.C.; Odds, F.C. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol 2005, 43, 284–292. [Google Scholar] [CrossRef] [PubMed]
- Ataides, F.S.; Costa, C.R.; Souza, L.K.H.; Fernández, O.L.; Jesuino, R.S.A.; Silva, M.R.R. Molecular identification and antifungal susceptibility profiles of Candida parapsilosis complex species isolated from culture collection of clinical samples. Rev Soc Bras Med Trop 2015, 48, 454–459. [Google Scholar] [CrossRef] [PubMed]
- CLSI. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts, Approved Guideline, CLSI document M44-A2, 2nd ed.; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2009. [Google Scholar]
- CLSI. Performance Standards for Antifungal Susceptibility Testing of Yeasts, CLSI supplement M27M44S, 2nd ed.; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2022. [Google Scholar]
- Aburto, I.; Espinoza, G.; Silva, V.; Rodríguez, H.; Moreno, G. Costo efectividad en protocolos de limpieza de piel en pacientes con úlceras. Rev Chil Heridas & Ostomias 2017, 8, 33–42. [Google Scholar]
- Schliemann, S. Limitations of skin protection. Curr Problem Dermatol 2007, 34, 171–177. [Google Scholar] [CrossRef]
- Silva, V.; Cabrera, M.; Díaz, M.C.; Abarca, C.; Hermosilla, G. Prevalencia de serotipos de Candida albicans en aislamientos de hemocultivo en Chile y primer caso de candidemia por C. dubliniensis. Rev Iberoam Micol 2003, 20, 46–51. [Google Scholar] [PubMed]
- Alburquenque, C.; Silva, V.A.; Fuentes, M.; Tapia, C.; Silva, V. Susceptibilidad in vitro a anidulafungina en 100 cepas de especies de Candida aisladas de muestras clínicas previo a la introducción de esta equinocandina en Chile. Rev Chil Infect 2011, 28, 399–403. [Google Scholar] [CrossRef]
- Badiee, P.; Boekhout, T.; Haddadi, P.; Mohammadi, R.; Ghadimi-Moghadam, A.; Soltani, J.; Zarei-Mahmoudabadi, A.; Ayatollahi-Mousavi, S.A.; Najafzadeh, M.J.; Diba, K.; Salimi-Khorashad., A.R.; Amin-Shahidi, M.; Ghasemi, F.; Jafarian, H. Epidemiology and Antifungal Susceptibility of Candida Species Isolated from 10 Tertiary Care Hospitals in Iran. Microbiol Spectr 2022, 10, e0245322. [Google Scholar] [CrossRef]



| Candida species | Primers name | Specific Sequence 5´- 3´ | Position gen | Fragment size |
|---|---|---|---|---|
| C. albicans | Ca-F1 Ca-3RF |
TACACTGACGGAGCGAGC AAAGCGATCCCGCCTTACC |
18S – 1455bp ITS2 – 93bp |
724bp |
| C. dubliniensis | Cd-2F Cd-3RC |
TGTTCTGGACAAACTTGC CAAGCAATCTCCGCCTTAT |
ITS1 – 31bp IST2 – 97bp |
354bp |
| Nakaseomyces glabrata (C. glabrata) | Cg-1F Cg-3RC |
CCAAGTCCTTGTGGCTTG ACTGATATGGCCTACAAT |
18S – 679bp ITS2 – 45bp |
1725bp |
| Pichia kudriavzeveii (C. krusei) | Ck-1F Ck-2RC |
TACCTATGGTAAGCACTG TTCGTTCCGCTCACGCAG |
18S – 634bp ITS1 – 19bp |
1200bp |
| C. parapsilosis complex | Cpc-1K Cpc-2RC |
TCCGGATTGGTTTAGAGA GCCCCATATAGAAGGCCT |
18S – 1660bp ITS1 – 72bp |
210bp |
| C. tropicalis | Ct-2F Ct-3RC |
GGTGGCGGGAGCAATCCT TGTGGTGGCCACTAGCAA |
ITS1 – 20bp ITS2 – 90bp |
340bp |
| Yeast Cultures | Medicine | Nurses | Medical Lab. Scientist | Total |
|---|---|---|---|---|
| Positive | 8 (10.3%) | 12 (13.5%) | 7 (7.5%) | 27 (10.4%) |
| Negative | 70 (89.3%) | 77 (86.5%) | 86 (92.5%) | 233 (89.6%) |
| Total | 78 (100%) | 89 (100%) | 93 (100%) | 260 (100%) |
| Yeast Cultures | Nurse B – PC – C |
Medicine B – PC – C |
MTS B – PC – C |
Total N°(%) B – PC – C |
|---|---|---|---|---|
| Positive | 6 – 4 – 2 | 4 – 4 – 0 | 2 – 5 – 0 | 12(13.5) – 13 (13.5) – 2(2.7)* |
| Negative | 24 – 23 – 30 | 26 – 26 – 18 | 27 – 34 – 25 | 77(86.5) – 83 (86.5) – 73(97.3) |
| Total | 30 – 27 – 32 | 30 – 30 – 18 | 29 – 39 – 25 | 89(100) – 96(100) – 75(100) |
| Daily handwashing frequency | Antiseptic soap | |||||
|---|---|---|---|---|---|---|
| Yeast Cultures | <3 | 4–6 | >7 | Total | No | Yes |
| Positive | 3 (15.8%) | 15 (13,5%) | 9 (7%) | 27 (10.4%) | 18 (14.2%) | 9 (6.8%) |
| Negative | 16 (86.5%) | 97 (86.5%) | 120 (93%) | 233 (89.6%) | 109 (85.8%) | 124 (93.2%) |
| Total | 19 (100%) | 112 (100%) | 129 (100%) | 260 (100%) | 127 (100%) | 133 (100%) |
| Yeast Cultures | No | 1-2 | 3-4 | >5 | Total |
|---|---|---|---|---|---|
| Positive | 17 (14.4%) | 7 (9%) | 2 (6.1%) | 1 (3.2%) | 27 (10.4%) |
| Negative | 101 (85.6%) | 71 (91%) | 31 (93.9%) | 30 (96.8%) | 233 (89.6%) |
| Total | 118 (100%) | 78 (100%) | 33 (100%) | 31 (100%) | 260 (100%) |
| Yeast Cultures | No | 1 | 2-3 | >4 | Total |
|---|---|---|---|---|---|
| Positive | 11 (10.5%) | 14 (16.5%) | 2 (3.4%)* | 0 (0%)* | 27 (10.4%) |
| Negative | 94 (89.5%) | 71 (83.5%) | 56 (96.6%) | 12 (100%) | 233 (89.6%) |
| Total | 105 (100%) | 85 (100%) | 58 (100%) | 100 (100%) | 260 (100%) |
| Yeast Species | Nurses | Medicine | MLS | Total |
|---|---|---|---|---|
| C. parapsilosis senso stricto | 10 | 7 | 5* | 22 (81.5%) |
| Meyerozyma guilliermondii | 1 | 1 | 0 | 2 (7.4%) |
| Trichosporon mucoides | 0 | 0 | 2 | 2 (7.4%) |
| Rhodotorula mucilagenosa | 1 | 0 | 0 | 1 (3.7%) |
| Total | 12 | 8 | 7 | 27 (100%) |
| Voticonazole | Anidulafingin | Caspofungin | ||||
|---|---|---|---|---|---|---|
| MIC mg/mL | S % | MIC mg/mL | S % | MIC mg/mL | S % | |
| Range | 0.5 - 1 | 100% | 0.5 - 2 | 100% | 0.125 - 1 | 100% |
| MIC 50 | 1 | 100% | 1 | 100% | 1 | 100% |
| MIC 90 | 1 | 100% | 2 | 100% | 1 | 100% |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).